Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 7,801-7,812 of 12,112
Drug study icon
CompletedNCT03247543

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD

This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.

Multiple locations, including Long Beach
ADHDOtherFrom 6 Years to 11 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT04016779

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication SPN-812 can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Garden Grove
ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03247517

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD

This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.

Multiple locations, including Dothan
ADHDOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03247530

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD

This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.

Multiple locations, including Dothan
ADHDOtherFrom 6 Years to 11 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Other study type icon
Enrolling By InvitationNCT03970005

Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis

This study is looking at evaluate the long-term outcomes among individuals participating in this clinical service for people with Prodromal Schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Columbus
SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
Ohio State University
Condition
Schizophrenia
Drug study icon
CompletedNCT00050804

Evaluation of Stress Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
PTSDDrugA study involving a medication or substance.
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
PTSD
Other study type icon
TerminatedNCT01663974

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolarity

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

Multiple locations, including Aix-en-Provence
Bipolarity, DepressionOtherOver 18 Years
Countries
France
Sponsor
AstraZeneca
Condition
Bipolarity, Depression
Behavioral study icon
TerminatedNCT01324648

Evaluation of the Bounce Back Program

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Calgary
DepressionOtherOver 19 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.